Nancy A. Grygiel, SVP and CCO at Amgen Inc. ($AMGN), sold $AMGN shares on the open market three times over the past year for a total of $1.43 million. Her latest sale occurred on November 20, 2025. These transactions rank 4,141st among 11,678 insiders, below the average sale value of $8.6 million across 6.4 transactions per insider. Grygiel made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | F | Common Stock | 787 | $366.21 | 8,594.1873 | 538,800,000 | 8.39% | 0.00% |
| March 3, 2026 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | A | Common Stock | 2010 | $0.00 | 9,354.4650 | 538,800,000 | 27.37% | 0.00% |
| Nov. 20, 2025 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | S | Common Stock | 1639 | $337.26 | 7,329.6847 | 538,500,000 | 18.27% | 0.00% |
| Nov. 20, 2025 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | M | Nqso (Right to Buy) | 1639 | $0.00 | 0.0000 | 538,500,000 | 100.00% | 0.00% |
| Nov. 20, 2025 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | M | Nqso (Right to Buy) | 1500 | $0.00 | 1,970.0000 | 538,500,000 | 43.23% | 0.00% |
| Nov. 20, 2025 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | M | Common Stock | 1500 | $177.46 | 8,829.6847 | 538,500,000 | 20.46% | 0.00% |
| Nov. 20, 2025 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | M | Common Stock | 1639 | $162.60 | 8,968.6847 | 538,500,000 | 22.36% | 0.00% |
| Nov. 20, 2025 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | S | Common Stock | 1500 | $337.26 | 7,329.6847 | 538,500,000 | 16.99% | 0.00% |
| Aug. 20, 2025 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | S | Common Stock | 1267 | $296.99 | 7,312.8077 | 538,300,000 | 14.77% | 0.00% |
| May 6, 2025 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | A | Common Stock | 591 | $0.00 | 8,565.9274 | 536,900,000 | 7.41% | 0.00% |
| May 6, 2025 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | A | Nqso (Right to Buy) | 3824 | $270.44 | 3,824.0000 | 536,900,000 | 9999.99% | 0.00% |
| May 2, 2025 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | F | Common Stock | 111 | $283.78 | 7,974.9274 | 536,900,000 | 1.37% | 0.00% |
| May 2, 2025 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | F | Common Stock | 118 | $283.78 | 8,085.9274 | 536,900,000 | 1.44% | 0.00% |
| April 30, 2025 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | F | Common Stock | 113 | $288.56 | 8,203.9274 | 536,900,000 | 1.36% | 0.00% |
| March 17, 2025 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | F | Common Stock | 524 | $313.71 | 8,316.9274 | 536,900,000 | 5.93% | 0.00% |
| March 3, 2025 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | A | Common Stock | 1503 | $0.00 | 8,815.2192 | 536,900,000 | 20.55% | 0.00% |
| Feb. 5, 2025 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | S | Common Stock | 1589 | $304.47 | 7,312.2192 | 536,900,000 | 17.85% | 0.00% |
| July 31, 2024 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | F | Common Stock | 1565 | $333.28 | 8,871.6967 | 537,200,000 | 15.00% | 0.00% |
| May 7, 2024 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | A | Common Stock | 499 | $0.00 | 10,399.9653 | 535,400,000 | 5.04% | 0.00% |
| May 7, 2024 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | A | Nqso (Right to Buy) | 3244 | $300.30 | 3,244.0000 | 535,400,000 | 9999.99% | 0.00% |
| May 5, 2024 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | F | Common Stock | 82 | $311.29 | 9,900.9653 | 535,400,000 | 0.82% | 0.00% |
| May 2, 2024 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | F | Common Stock | 114 | $277.37 | 12,099.9653 | 535,400,000 | 0.93% | 0.00% |
| May 3, 2024 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | S | Common Stock | 2117 | $313.09 | 9,982.9653 | 535,400,000 | 17.50% | 0.00% |
| April 30, 2024 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | F | Common Stock | 106 | $276.38 | 12,213.9653 | 535,400,000 | 0.86% | 0.00% |
| March 18, 2024 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | F | Common Stock | 703 | $268.87 | 12,319.9653 | 535,400,000 | 5.40% | 0.00% |
| March 6, 2024 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | A | Common Stock | 1954 | $0.00 | 12,964.3725 | 535,400,000 | 17.75% | 0.00% |
| Dec. 4, 2023 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | S | Common Stock | 2096 | $273.03 | 10,972.3725 | 534,000,000 | 16.04% | 0.00% |
| Nov. 5, 2023 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | F | Common Stock | 249 | $269.86 | 13,068.3725 | 534,000,000 | 1.87% | 0.00% |
| July 31, 2023 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | F | Common Stock | 1129 | $236.37 | 13,192.5699 | 534,000,000 | 7.88% | 0.00% |
| May 5, 2023 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | F | Common Stock | 54 | $231.89 | 14,320.6422 | 534,000,000 | 0.38% | 0.00% |
| May 3, 2023 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | F | Common Stock | 62 | $235.97 | 14,374.6422 | 534,000,000 | 0.43% | 0.00% |
| May 2, 2023 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | A | Nqso (Right to Buy) | 5375 | $0.00 | 5,375.0000 | 534,000,000 | 9999.99% | 0.00% |
| May 2, 2023 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | A | Common Stock | 635 | $0.00 | 14,436.6422 | 534,000,000 | 4.60% | 0.00% |
| April 30, 2023 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | F | Common Stock | 73 | $239.74 | 13,801.6422 | 534,000,000 | 0.53% | 0.00% |
| March 17, 2023 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | F | Common Stock | 339 | $234.57 | 13,874.6422 | 534,000,000 | 2.39% | 0.00% |
| March 6, 2023 | AMGEN INC | $AMGN | Grygiel Nancy A. | SVP & CCO | A | Common Stock | 968 | $0.00 | 14,127.7528 | 534,000,000 | 7.36% | 0.00% |